Whitney L. Hensing
First author of the Oncotarget review on HER2-low breast cancer, affiliated with the University of Missouri KC School of Medicine.
Best podcasts with Whitney L. Hensing
Ranked by the Snipd community
4 snips
Feb 12, 2025 • 8min
HER2-Low Breast Cancer: A New Understanding
Whitney L. Hensing, a prominent researcher from the University of Missouri KC School of Medicine, delves into the newly recognized category of HER2-low breast cancer. She discusses how this evolved classification impacts treatment decisions, particularly the role of novel therapies like antibody drug conjugates. Hensing highlights the significance of ongoing research improving diagnostics and access to therapies for this patient group, revealing a new frontier in breast cancer management that could change lives.
